The aim of the Education Committee (EC) is to coordinate ESOT’s efforts to advance multidisciplinary education for transplant professionals at all career levels and to contribute to their professional development.
The Basic Science Committee promotes scientific issues and transplantation research within ESOT. An active basic science community and an efficient translation of innovation into the clinic are crucial for the future of transplantation medicine.
The European Transplant Allied Healthcare Professionals (ETAHP) reaches out to allied healthcare professionals throughout Europe in order to ensure the best care possible for all transplant patients, with the aim to optimize patient outcomes.
The Young Professionals in Transplantation (YPT) is the Network for Junior Transplant professionals of ESOT, representing all young transplant clinicians and scientists who are beginning a career in transplantation and organ donation.
The mission of ECTORS is to provide a forum for discussing and stimulating novel developments in the fields of cellular therapies in organ transplantation, organ regeneration and generation of new organs from stem cells and biomaterials.
ECTTA is the forum for experience exchange on treatment of patients with end-stage heart and lung failure. Our aim is to improve outcomes for the patients.
EDTCO aims to support health care professionals to provide clinically effective programmes on organ and tissue donation, procurement and transplantation.
EKITA is the Organ Expert Section of ESOT on kidney transplantation in Europe, providing a forum for kidney transplantation professionals to exchange scientific information and views aimed at providing the best service to European patients .
The European Liver and Intestine Transplant Association (ELITA), previously known as the European Liver Transplant Association (ELTA), is a section of ESOT. Its membership represents the expertise on liver and intestinal transplantation in Europe.
ELPAT is a European platform that brings continuity and progress in European research and dialogue on "Ethical, Legal and Psychosocial Aspects of organ Transplantation". ELPAT currently consists of over 160 experts from more than 25 European countries.
EPITA is established to provide a forum for those working in the field of pancreas and islet of Langerhans transplantation or any other alternative form of beta cell replacement in Europe, to exchange scientific information and views related primarily to providing the best service for patients in Europe requiring pancreas or islet transplantation.
VCA has opened a new era in the field of transplantation, reconstructive and restorative surgery. This Section brings together 10 representatives of major European teams at the forefront in this field.
We are thrilled to announce that TransplantToux is embarking on an exciting journey to Athens, Greece, to attend the renowned ESOT Congress. In a unique endeavour, they will be cycling their way to Athens, showcasing their commitment to the field of transplantation and raising awareness for organ donation. TransplantToux is a passionate group of individuals
The ESOT Patient Inclusion Initiative Steering Committee is delighted to announce the Patient Inclusivity Events at the ESOT Congress 2023 in Athens, Greece. These events cover workshops and sessions to help foster the relationship between patient advocates and healthcare professionals.
The framework and case studies demonstrate the common features of successful organ donation and transplantation systems, and highlight transferrable elements that can be applied elsewhere with the aim of improving performance.
The steering group members of the ESOT-ETPO Alliance are delighted to announce three new appointments for activities happening in conjunction with the ESOT Congress 2023 in Athens, Greece. The traditional appointment with the members of the ESOT-ETPO Alliance network is enhanced this year with the possibility for the transplanted community to attend two workshops (both
We would like to extend a huge thank you to everyone who joined ESOT at TLJ 3.0 and supported us on our mission to transform the world of transplantation and improve the lives of people living with transplants. We are excited to see the impact of these newly formed consensus reports and hope they assist in guiding the future of transplantation. However, we recognise there is still a long way to go. Our work does not stop here, and we look forward to continuing to strive towards a brighter future for transplantation at many more meetings in the years to come.
This handbook formalises the processes associated with the preparation of ESOT CPGs, including selecting topics for new guidelines, writing and reviewing approval, dissemination, and updating. Moreover, it defines the governance of the process.
The Swiss Transplant Cohort Study (STCS) identified 13 research priorities through focus group interviews with transplant patients. The priorities were assigned to four levels, addressing 1) individual patient level priorities such as medication taking, exercise and physical fitness, or dealing with financial pressure; 2) micro level priorities covering social interactions such as trustful relationships, person-centredness;
Keep up with ESOT – save the dates 🗓 10 August at 21:00 CEST #ESOTchat on Twitter >>> #ESOTTLJ with Irene Bello, Arne Neyrinck, Maria Simonenko and Cristiano Amarelli on Cardiothoracic Topics 🗓 24 August at 21:00 CEST #ESOTchat on Twitter >>> #ESOTTLJ with Lucrezia Furian and Lorna Marson on Kidney Topics
In the last 8 weeks, specialised paediatric liver centres in the UK identified more children with acute liver failure due to hepatitis of an unknown cause than would be expected over a similar period.
Read a statement on the outbreak from ELITA
We announce the release of the Open Letter prepared with the European Donation and Transplant Coordination Organisation (EDTCO) to support the modification of the Swiss transplant law to reform the national organ consent system (votation May 15, 2022), moving from explicit to presumed consent. Read here the full Open Letter to Swisstransplant.
